MA53009A - Agents inhibiteurs d'ask1 - Google Patents
Agents inhibiteurs d'ask1Info
- Publication number
- MA53009A MA53009A MA053009A MA53009A MA53009A MA 53009 A MA53009 A MA 53009A MA 053009 A MA053009 A MA 053009A MA 53009 A MA53009 A MA 53009A MA 53009 A MA53009 A MA 53009A
- Authority
- MA
- Morocco
- Prior art keywords
- ask1 inhibitors
- ask1
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690674P | 2018-06-27 | 2018-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53009A true MA53009A (fr) | 2021-05-05 |
Family
ID=67254023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053009A MA53009A (fr) | 2018-06-27 | 2019-06-26 | Agents inhibiteurs d'ask1 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11814362B2 (fr) |
| EP (1) | EP3814333A1 (fr) |
| JP (1) | JP2021528456A (fr) |
| KR (1) | KR20210024532A (fr) |
| CN (1) | CN112638896A (fr) |
| AR (1) | AR115636A1 (fr) |
| AU (1) | AU2019291806A1 (fr) |
| BR (1) | BR112020026423A2 (fr) |
| CA (1) | CA3104662A1 (fr) |
| CL (1) | CL2020003375A1 (fr) |
| CO (1) | CO2021000782A2 (fr) |
| CR (1) | CR20210049A (fr) |
| EA (1) | EA202190034A1 (fr) |
| IL (1) | IL279709A (fr) |
| JO (1) | JOP20200318A1 (fr) |
| MA (1) | MA53009A (fr) |
| MX (1) | MX2020013895A (fr) |
| PE (1) | PE20211379A1 (fr) |
| SG (1) | SG11202012784SA (fr) |
| TW (1) | TW202035389A (fr) |
| UY (1) | UY38278A (fr) |
| WO (1) | WO2020006031A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE064531T2 (hu) | 2018-06-27 | 2024-04-28 | Bristol Myers Squibb Co | Szubsztituált naftiridinon vegyületek mint T-sejt aktivátorok |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| TWI598347B (zh) * | 2009-07-13 | 2017-09-11 | 基利科學股份有限公司 | 調節細胞凋亡信號之激酶的抑制劑 |
| UY35212A (es) * | 2012-12-21 | 2014-06-30 | Gilead Sciences Inc | Inhibidores de la quinasa que regula la señal de la apoptosis |
| MX2016008254A (es) * | 2013-12-20 | 2016-10-14 | Gilead Sciences Inc | Inhibidores de cinasa reguladora de la señal de apoptosis. |
| WO2018151830A1 (fr) | 2017-02-17 | 2018-08-23 | Fronthera U.S. Pharmaceuticals Llc | Inhibiteurs de kinase de régulation du signal apoptotique à base de pyridinyle |
-
2019
- 2019-06-26 WO PCT/US2019/039156 patent/WO2020006031A1/fr unknown
- 2019-06-26 TW TW108122356A patent/TW202035389A/zh unknown
- 2019-06-26 US US17/253,269 patent/US11814362B2/en active Active
- 2019-06-26 AR ARP190101780A patent/AR115636A1/es unknown
- 2019-06-26 EA EA202190034A patent/EA202190034A1/ru unknown
- 2019-06-26 MA MA053009A patent/MA53009A/fr unknown
- 2019-06-26 EP EP19739494.3A patent/EP3814333A1/fr active Pending
- 2019-06-26 AU AU2019291806A patent/AU2019291806A1/en not_active Abandoned
- 2019-06-26 KR KR1020217000614A patent/KR20210024532A/ko unknown
- 2019-06-26 BR BR112020026423-7A patent/BR112020026423A2/pt not_active Application Discontinuation
- 2019-06-26 PE PE2020002138A patent/PE20211379A1/es unknown
- 2019-06-26 MX MX2020013895A patent/MX2020013895A/es unknown
- 2019-06-26 JP JP2020572645A patent/JP2021528456A/ja active Pending
- 2019-06-26 UY UY0001038278A patent/UY38278A/es not_active Application Discontinuation
- 2019-06-26 CR CR20210049A patent/CR20210049A/es unknown
- 2019-06-26 CN CN201980042586.9A patent/CN112638896A/zh active Pending
- 2019-06-26 JO JOP/2020/0318A patent/JOP20200318A1/ar unknown
- 2019-06-26 CA CA3104662A patent/CA3104662A1/fr not_active Abandoned
- 2019-06-26 SG SG11202012784SA patent/SG11202012784SA/en unknown
-
2020
- 2020-12-23 CL CL2020003375A patent/CL2020003375A1/es unknown
- 2020-12-23 IL IL279709A patent/IL279709A/en unknown
-
2021
- 2021-01-25 CO CONC2021/0000782A patent/CO2021000782A2/es unknown
-
2023
- 2023-10-05 US US18/377,125 patent/US20240109867A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JOP20200318A1 (ar) | 2020-12-10 |
| KR20210024532A (ko) | 2021-03-05 |
| TW202035389A (zh) | 2020-10-01 |
| US20240109867A1 (en) | 2024-04-04 |
| PE20211379A1 (es) | 2021-07-27 |
| WO2020006031A8 (fr) | 2020-09-24 |
| IL279709A (en) | 2021-03-01 |
| SG11202012784SA (en) | 2021-01-28 |
| MX2020013895A (es) | 2021-07-21 |
| UY38278A (es) | 2020-01-31 |
| EP3814333A1 (fr) | 2021-05-05 |
| CR20210049A (es) | 2021-07-01 |
| WO2020006031A1 (fr) | 2020-01-02 |
| CL2020003375A1 (es) | 2021-09-03 |
| CO2021000782A2 (es) | 2021-01-29 |
| CN112638896A (zh) | 2021-04-09 |
| EA202190034A1 (ru) | 2021-04-08 |
| US11814362B2 (en) | 2023-11-14 |
| BR112020026423A2 (pt) | 2021-03-23 |
| CA3104662A1 (fr) | 2020-01-02 |
| US20210115020A1 (en) | 2021-04-22 |
| AR115636A1 (es) | 2021-02-10 |
| JP2021528456A (ja) | 2021-10-21 |
| AU2019291806A1 (en) | 2021-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA51616A (fr) | Inhibiteurs d'adn-pk | |
| MA44725A (fr) | Formulations d'un inhibiteur de lsd1 | |
| MA54543A (fr) | Inhibiteurs de kif18a | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
| DK3497103T3 (da) | Pyridopyrimdinon-cdk2/4/6-inhibitorer | |
| DK3687994T3 (da) | Gadolinium-bærende pcta-baserede kontrastmidler | |
| MA52413A (fr) | Inhibiteurs de cd73 | |
| MA51066A (fr) | Inhibiteurs d'intégrine | |
| MA50456A (fr) | Formulations d'un inhibiteur de kinase trk macrocyclique | |
| MA52942A (fr) | Composés inhibiteurs d'oga | |
| UA42295S (uk) | Комп'ютер | |
| MA52812A (fr) | Inhibiteurs de sarm1 | |
| MA52939A (fr) | Composés inhibiteurs d'oga | |
| DK3606519T3 (da) | ASK1-inhibitorforbindelser og anvendelser deraf | |
| MA47420A (fr) | Composés inhibiteurs d'oga | |
| DK3774817T3 (da) | Bcl6-hæmmere | |
| MA49006A (fr) | Inhibiteurs d'ip6k | |
| MA50906A (fr) | Inhibiteurs d'immunoprotéasome | |
| UA42369S (uk) | Комп'ютер | |
| MA54521A (fr) | Dérivés d'oxopyridine substitués | |
| MA52813A (fr) | Inhibiteurs de sarm1 | |
| MA52809A (fr) | Inhibiteurs de sarm1 | |
| MA51611A (fr) | Inhibiteurs de pi4kiiibêta | |
| MA52935A (fr) | Composés inhibiteurs d'oga |